BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 15562953)

  • 1. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
    Santha T; Thomas A; Chandrasekaran V; Selvakumar N; Gopi PG; Subramani R; Rajeswari R; Rani B; Paramasivan CN; Perumal M; Wares F; Narayanan PR
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):52-7. PubMed ID: 16466037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
    Bercion R; Kuaban C
    Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
    Angrup A; Varma-Basil M; Kumar S; Pathak RK; Sharma H; Banavaliker JN; Bose M
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):122-7. PubMed ID: 21323174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India.
    Joseph BV; Soman S; Radhakrishnan I; Madhavilatha GK; Paul LK; Mundayoor S; Kumar RA
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):494-9. PubMed ID: 19335956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.
    Mahajan M; Agarwal DS; Gadre DJ; Singh NP; Gupta HC; Talwar V
    J Commun Dis; 1996 Mar; 28(1):15-9. PubMed ID: 8778175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.